Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective

被引:19
|
作者
Watermeyer, Tamlyn [1 ,3 ]
Calia, Clara [2 ,3 ]
机构
[1] Univ Edinburgh, Edinburgh Dementia Prevent, Ctr Clin Brain Sci, 9a Bioquarter Little France Rd, Edinburgh EH16 4BX, Midlothian, Scotland
[2] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland
[3] Univ Edinburgh, Ctr Global Hlth Res, Global Prevent Dementia Programme GloDePP, Edinburgh, Midlothian, Scotland
关键词
ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS;
D O I
10.7189/jogh.09.010317
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
    Vos, Stephanie J. B.
    Xiong, Chengjie
    Visser, Pieter Jelle
    Jasielec, Mateusz S.
    Hassenstab, Jason
    Grant, Elizabeth A.
    Cairns, Nigel J.
    Morris, John C.
    Holtzman, David M.
    Fagan, Anne M.
    LANCET NEUROLOGY, 2013, 12 (10) : 957 - 965
  • [42] Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
    Brookmeyer, Ron
    Abdalla, Nada
    ALZHEIMERS & DEMENTIA, 2018, 14 (08) : 981 - 988
  • [43] Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment
    Grill, Joshua D.
    Karlawish, Jason
    Elashoff, David
    Vickrey, Barbara G.
    ALZHEIMERS & DEMENTIA, 2013, 9 (03) : 356 - 359
  • [44] Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease
    Edmonds, Emily C.
    Delano-Wood, Lisa
    Galasko, Douglas R.
    Salmon, David P.
    Bondi, Mark W.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (01) : 231 - 242
  • [45] Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease
    Barba, Lorenzo
    Abu Rumeileh, Samir
    Bellomo, Giovanni
    Paoletti, Federico Paolini
    Halbgebauer, Steffen
    Oeckl, Patrick
    Steinacker, Petra
    Massa, Federico
    Gaetani, Lorenzo
    Parnetti, Lucilla
    Otto, Markus
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (01) : 83 - 86
  • [46] Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States
    Brookmeyer, Ron
    Abdalla, Nada
    Kawas, Claudia H.
    Corrada, Maria M.
    ALZHEIMERS & DEMENTIA, 2018, 14 (02) : 121 - 129
  • [47] Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease
    Perin, Stephanie
    Harrington, Karra D.
    Lim, Yen Ying
    Ellis, Kathryn
    Ames, David
    Pietrzak, Robert H.
    Schembri, Adrian
    Rainey-Smith, Stephanie
    Salvado, Olivier
    Laws, Simon M.
    Martins, Ralph N.
    Villemagne, Victor L.
    Rowe, Christopher C.
    Masters, Colin L.
    Maruff, Paul
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 229 : 269 - 274
  • [48] Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease
    Dillen, Kim N. H.
    Jacobs, Heidi I. L.
    Kukolja, Juraj
    Richter, Nils
    von Reutern, Boris
    Onur, Ozgur A.
    Langen, Karl-Josef
    Fink, Gereon R.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 59 (01) : 169 - 187
  • [49] Pathology of clinical and preclinical Alzheimer's disease
    Thal, Dietmar Rudolf
    von Arnim, Christine
    Griffin, W. Sue T.
    Yamaguchi, Haruyasu
    Mrak, Robert E.
    Attems, Johannes
    Upadhaya, Ajeet Rijal
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2013, 263 : S137 - S145
  • [50] A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach
    Jutten, Roos J.
    Thompson, Louisa
    Sikkes, Sietske A. M.
    Maruff, Paul
    Luis Molinuevo, Jose
    Zetterberg, Henrik
    Alber, Jessica
    Faust, David
    Gauthier, Serge
    Gold, Michael
    Harrison, John
    Lee, Athene K. W.
    Snyder, Peter J.
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 86 (02) : 511 - 524